Cite
APA Citation
Grohe, C., Gleiber, W., Haas, S., Mueller-Huesmann, H., Schulze, M., Atz, J., & Kaiser, R. (n.d.). 55PEfficacy and safety of nintedanib and docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): First interim results of the ongoing non-interventional study VARGADO (NCT02392455). Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095502245.0x000031